More News! For those who want to keep up with everything

More News! 8 Apr 2017

These Scientists are Turning the Human Brain into Art

Neuroimaging artist duo DiMa takes the popular saying “beauty is inside” to another level by transforming complex visualizations of the brain into art. Diana Roettger and Matthew Rowe, who work together under the artistic name DiMa, are two imaging scientists that create art directly from scientific research. Originally from Germany and the UK, respectively, both hold […]

April 8, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

More News! 7 Apr 2017

This Biotech Mining Probiotics to Treat the Skin has IPO’d in London

SkinBioTherapeutics has raised £4,5M in its IPO on the London Stock Exchange to advance its probiotic technology for skin health applications. SkinBioTherapeutics, a spin-out from the University of Manchester, made its debut this week in AIM, the London Stock Exchange’s market for smaller growing companies. The £4,5M (€5.25M) raised will be used to continue the development […]

April 7, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 6 Apr 2017

Fear & Loathing in GMOs: How do you change concerned minds?

The house was packed to hear Joyce Tait of the Innogen Institute and Mark Lynas, an environmental writer, speak about smarter approaches to GM regulations. The second day of SynBioBeta yesterday started early, but fuelled by a passion for synthetic biology (on which a number of speakers commented), attendees packed into the lecture hall for a fireside chat on GMO regulation with Joyce […]

April 6, 2017 - 5 minutesmins - By Evelyn Warner

More News! 4 Apr 2017

SynBioBeta Launches Venture Fund for Synthetic Biology Startups

US-based venture capital fund Data Collective has announced that it is partnering with SynBioBeta to launch a new synthetic biology venture fund. Data Collective will join forces with SynBioBeta founder John Cumbers to launch the DCVC SynBioBeta fund, a pre-seed and seed VC fund to invest in synthetic biology startups. John Cumbers, an expert on […]

April 4, 2017 - 2 minutesmins - By Melanie De Almeida

More News! 3 Apr 2017

First Treatment for Severe Premenstrual Syndrome Clears Phase II

Swedish Asarina Pharma has announced positive results of a Phase IIa study for the treatment of Premenstrual Dysphoric Disorder (PMDD). With only a single product candidate in its pipeline, Asarina Pharma is focusing on the development of the first potential therapy for the treatment of PMDD, a severe and disabling form of premenstrual syndrome that affects about 5% of […]

April 3, 2017 - 3 minutesmins - By Melanie De Almeida

More News! 1 Apr 2017

Will we Rely on Biomining to Build the Tech Devices of the Future?

The Danish artist Jacob Remin explores how biotech might be essential if we want to keep building smartphones and laptops. Computers, tablets, phones, television screens… we take our electronic devices for granted. However, the rapidly increasing demand might not be possible to meet because of rare earth elements, a series of rare metals that are […]

April 1, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

More News! 29 Mar 2017

More “FDA Love” for Cannabis Company with Orphan Drug Designation

Last year was a doozy for biotech, but it was spectacular for GW Pharmaceuticals. Its streak continues with more special treatment. GW Pharmaceuticals, which is developing epilepsy treatments from marijuana, is making a name for itself not just as “that company” turning a recreational drug into medical ones; the company was also one of 2016’s surprise successes — its […]

March 29, 2017 - 2 minutesmins - By Evelyn Warner

More News! 21 Mar 2017

Better than Quantum Computing: The EU Launches a Biocomputer Project

The EU Horizon 2020 has launched Bio4Comp, a five-year €6.1M project to build more powerful and safer biocomputers that could outperform quantum computing. The Bio4Comp project has the ambitious goal of building a computer with greater processing speed and lower energy consumption than any of the most advanced computers existing today. Ultimately, this could translate into […]

March 21, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 20 Mar 2017

UPDATE: Swiss Medtech cancels IPO and goes for Record €411M Exit

UPDATE (10/04/2017): Symetis has decided to cancel its IPO following its acquisition by Boston Scientific in a €411M deal. The Swiss medtech company Symetis has launched a €55M IPO to accelerate the development of its next-generation heart valve replacement solutions. Symetis develops next-generation heart valve replacements for the treatment of cardiac valve conditions. With its […]

March 20, 2017 - 2 minutesmins - By Melanie De Almeida

Research Integrin beta 3 cellular senescence

More News! 9 Mar 2017

There’s a New Target for Anti-Aging Therapies

According to a study at Queen Mary University of London (QMUL) published in the journal Cell Reports, the protein integrin-ß3 is a new marker and regulator of cellular senescence. Past research has revealed that the rising number of senescent cells, which appear during normal ageing, contributes to many age-related diseases. In a new study by Ana O’Loghlen and collegues, integrin-ß3 has been identified as […]

March 9, 2017 - 3 minutesmins - By Melanie De Almeida

More News! 7 Mar 2017

UPDATE: Reproductive Health Biotech starts Phase III after €90M IPO

UPDATE (07/03/2017): ObsEva has announced the start of its Phase III trials for nolasiban, an oral oxytocin receptor antagonist. It is under evaluation for improvements in pregnancy and live birth rates following embryo transfer (ET). UPDATE (26/01/2017): ObsEva has disclosed plans to release 6.45M shares at $15 (€14) each, for a total of €90.3M. This large total reflects […]

March 7, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

electronic plants e plants bioelectronics Linköping

More News! 3 Mar 2017

Plants go Electronic with new Swedish Magic Sauce

e-Plants can become a reality with a new technique that creates in vivo electronic circuits. But what are these bioelectronic plants for? A research team from the Linköping University has developed a ‘magic sauce’ that can transform the normal vascular system, through which they transport water and nutrients from the roots, into an electronic circuit. […]

March 3, 2017 - 3 minutesmins - By Denise Neves Gameiro

Resources

Categories

Swiss biotech going strong in 2024: 18 companies to put on your radar

The ABC of biotech startup funding

Approaches

Therapeutic areas

Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR

Special Olympics: How is biotechnology revolutionizing sports performance worldwide?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us